trending Market Intelligence /marketintelligence/en/news-insights/trending/PuxtxQa_tSPdQRgOHO0w-A2 content esgSubNav
In This List

Bellerophon appoints board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Bellerophon appoints board member

Bellerophon Therapeutics Inc. appointed Ted Wang to its board of directors.

The company's board now has 10 members.

Wang is chief investment officer of asset manager Puissance Capital Management. He previously served as a partner at Goldman Sachs & Co.